# Pfizer Inc: Form 8-K, filed Feb 3, 2026

- Company: [Pfizer Inc](/companies/pfe.md) (CIK 78003)
- Form: 8-K
- Filed: 2026-02-03
- Accepted by EDGAR: Feb 3, 2026, 07:01 ET
- Period: 2026-02-03
- Accession: 0000078003-26-000005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/78003/000007800326000005/pfe-20260203.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/78003/000007800326000005/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/78003/000007800326000005/pfe-20260203.htm

Filed Feb 3, 2026.
Source: SEC EDGAR, the filing index for accession 0000078003-26-000005. Last ingested by Listed: Nov 12, 2026, 18:08 ET. No prices; not investment advice.